Cargando…
Adherence in allergen immunotherapy: Current situation and future implications
Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatme...
Autores principales: | Gehrt, Francesca, Xu, Qingqing, Baiardini, Ilaria, Canonica, Giorgio Walter, Pfaar, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707370/ https://www.ncbi.nlm.nih.gov/pubmed/36457724 http://dx.doi.org/10.5414/ALX02318E |
Ejemplares similares
-
Switching treatments in COPD: implications for costs and treatment adherence
por: Braido, Fulvio, et al.
Publicado: (2015) -
The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022) -
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
por: Sahiner, Umit M., et al.
Publicado: (2023) -
Clinical trials in allergen immunotherapy: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2018) -
Causes of Non-Adherence to Allergen-Specific Immunotherapy: A Foundation towards a Patient-Personalized Approach
por: Ridolo, Erminia, et al.
Publicado: (2023)